全球免疫檢測市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

全球免疫檢測市場預計將從2025年的383.9億美元成長到2034年的639.3億美元，2026年至2034年的複合年成長率（CAGR）為5.83%。隨著醫療專業人員越來越依賴免疫檢測技術進行精準的疾病診斷、治療監測和臨床研究，該市場正經歷強勁成長。免疫檢測能夠以高靈敏度和特異性檢測與感染疾病、癌症、心血管疾病、內分泌疾病和自體免疫疾病相關的生物標記。對疾病早期檢測和預防醫學的日益重視，正顯著推動全球市場的發展。

慢性病盛行率的不斷上升、診斷檢測手段的日益普及以及檢查室自動化技術的持續進步是推動市場成長的主要因素。醫療機構正在採用能夠提供快速、可靠且高通量檢測結果的先進免疫檢測分析儀。對診斷檢查室、個人化醫療和生物技術研究投入的增加，進一步強化了醫院、研究機構和臨床檢查室的需求。

前景極為光明，分子診斷、即時檢測和人工智慧 (AI) 的創新不斷推動診斷能力的提升。高通量多重檢測、自動化檢測流程和新一代生物標記分析技術的開發將提高檢測的準確性和效率。醫療保健支出的成長、疾病篩檢計畫的擴展以及技術的持續進步將支撐全球免疫檢測市場的長期持續成長。

我們的報告經過精心撰寫，旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵組成部分，旨在幫助您全面了解市場環境：

市場概覽：本節對市場進行了清晰的說明，包括關鍵定義、分類以及當前行業格局的概述。

市場動態：對影響市場成長的主要促進因素、限制因素、機會和挑戰進行詳細評估。這包括技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析：本部分根據產品類型、應用、最終用戶和地區將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和市場貢獻。

競爭格局：我們對主要市場參與企業進行了詳細評估，包括其市場定位、產品系列、策略舉措和財務表現。這有助於深入了解競爭趨勢和主要參與者所採取的策略。

市場預測：本部分提供基於數據的市場規模和成長模式預測，預測期為指定時期。它綜合考慮了歷史趨勢、當前市場狀況和定量分析，以識別預期的未來趨勢。

區域分析：這包括對主要地理區域的市場表現進行全面檢驗，確定高成長領域和區域趨勢，以更深入地了解每個區域特有的市場機會。

新趨勢與新機會：識別關鍵市場趨勢、技術進步和新興投資機會。本部分重點在於潛在成長領域和未來產業趨勢。

客製化選項：我們提供靈活的報告客製化服務，以滿足您的特定需求。這包括額外的細分、國家/地區分析、競爭對手分析、客製化資料點或針對特定細分市場的洞察，從而更有效地支援您的策略決策。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球免疫檢測市場：依產品與服務分類

• 市場分析、洞察與預測
• 試劑和試劑盒
• 分析儀/設備
• 軟體服務

第5章 全球免疫檢測市場：依技術分類

• 市場分析、洞察與預測
• 酵素免疫分析法（ELISA）
• 化學冷光免疫檢測（CLIA）
• 螢光免疫分析（FIA）
• 免疫測量（RIA）
• 側向流動免疫檢測（LFIA）
• 多重和微陣列免疫檢測
• 其他（西方墨點法、免疫PCR）

第6章 全球免疫檢測市場：依應用分類

• 市場分析、洞察與預測
• 感染疾病
• 腫瘤學
• 循環系統
• 內分泌學
• 自體免疫疾病
• 藥物監測
• 藥物發現與開發
• 其他

第7章 全球免疫檢測市場：依檢體類型分類

• 市場分析、洞察與預測
• 血液和血清
• 唾液
• 尿
• 其他體液

第8章 全球免疫檢測市場：依最終用戶分類

• 市場分析、洞察與預測
• 醫院
• 臨床實驗室
• 製藥和生物技術公司
• 學術研究機構
• 照護端/居家照護環境
• 其他

第9章 全球免疫檢測市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第10章 競爭格局

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第11章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Abbott Laboratories
  • F. Hoffmann-La Roche AG
  • Siemens Healthineers AG
  • Danaher Corporation
  • Thermo Fisher Scientific Inc
  • Becton Dickinson And Company
  • Bio-Rad Laboratories Inc
  • Hologic Inc
  • Luminex Corporation
  • QIAGEN NV
  • Sysmex Corporation
  • Agilent Technologies Inc
  • BioM erieux SA
  • DiaSorin SpA
  • Ortho Clinical Diagnostics
  • Tosoh Bioscience Inc
  • Shenzhen Mindray Bio-Medical
  • Merck KGaA
  • QuidelOrtho Corporation

The global immunoassay market size is expected to reach USD 63.93 Billion in 2034 from USD 38.39 Billion in 2025, growing at a CAGR of 5.83 during 2026-2034.This market is experiencing strong expansion as healthcare providers increasingly rely on immunoassay technologies for accurate disease diagnosis, therapeutic monitoring, and clinical research applications. Immunoassays provide highly sensitive and specific detection of biomarkers associated with infectious diseases, cancer, cardiovascular disorders, endocrine conditions, and autoimmune diseases. Growing emphasis on early disease detection and preventive healthcare is significantly supporting market development worldwide.

Increasing prevalence of chronic diseases, expanding diagnostic testing volumes, and continuous advancements in laboratory automation are major factors driving market growth. Healthcare facilities are adopting advanced immunoassay analyzers capable of delivering rapid, reliable, and high-throughput testing results. Rising investments in diagnostic laboratories, personalized medicine, and biotechnology research are further strengthening demand across hospitals, research institutions, and clinical laboratories.

The future outlook remains highly promising as innovations in molecular diagnostics, point-of-care testing, and artificial intelligence continue improving diagnostic capabilities. Development of highly multiplexed assays, automated laboratory workflows, and next-generation biomarker analysis will enhance testing accuracy and efficiency. Growing healthcare expenditure, expanding disease screening programs, and continuous technological advancements will support sustained long-term expansion across the global immunoassay market.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Product & Service

• Reagents & Kits
• Analyzers & Instruments
• Software & Services

By Technology

• Enzyme-Linked Immunosorbent Assay (ELISA)
• Chemiluminescence Immunoassay (CLIA)
• Fluorescence Immunoassay (FIA)
• Radioimmunoassay (RIA)
• Lateral Flow Immunoassay (LFIA)
• Multiplex & Microarray Immunoassays
• Others (Western Blot, Immuno-PCR)

By Application

• Infectious Diseases
• Oncology
• Cardiology
• Endocrinology
• Autoimmune Disorders
• Therapeutic Drug Monitoring
• Drug Discovery & Development
• Others

By Specimen Type

• Blood & Serum
• Saliva
• Urine
• Other Body Fluids

By End User

• Hospitals
• Clinical Laboratories
• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Point-of-Care/Home-Care Settings
• Others

COMPANIES PROFILED

• Abbott Laboratories, F. Hoffmann-La Roche AG, Siemens Healthineers AG, Danaher Corporation, Thermo Fisher Scientific Inc., Becton Dickinson and Company, Bio-Rad Laboratories Inc., Hologic Inc., Luminex Corporation, QIAGEN N.V., Sysmex Corporation, Agilent Technologies Inc., bioMerieux SA, DiaSorin S.p.A., Ortho Clinical Diagnostics, Tosoh Bioscience Inc., Shenzhen Mindray Bio-Medical, Merck KGaA, QuidelOrtho Corporation

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL IMMUNOASSAY MARKET: BY PRODUCT & SERVICE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product & Service
• 4.2. Reagents & Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Analyzers & Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Software & Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL IMMUNOASSAY MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Technology
• 5.2. Enzyme-Linked Immunosorbent Assay (ELISA) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Chemiluminescence Immunoassay (CLIA) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Fluorescence Immunoassay (FIA) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Radioimmunoassay (RIA) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Lateral Flow Immunoassay (LFIA) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Multiplex & Microarray Immunoassays Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. Others (Western Blot, Immuno-PCR) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL IMMUNOASSAY MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Infectious Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Oncology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Cardiology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Endocrinology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Autoimmune Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.7. Therapeutic Drug Monitoring Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.8. Drug Discovery & Development Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.9. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL IMMUNOASSAY MARKET: BY SPECIMEN TYPE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Specimen Type
• 7.2. Blood & Serum Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Saliva Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Urine Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Other Body Fluids Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL IMMUNOASSAY MARKET: BY END USER 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast End User
• 8.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Clinical Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.4. Pharmaceutical & Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.5. Academic & Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.6. Point-of-Care/Home-Care Settings Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL IMMUNOASSAY MARKET: BY REGION 2022-2034 (USD MN)

• 9.1. Regional Outlook
• 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.2.1 By Product & Service
  • 9.2.2 By Technology
  • 9.2.3 By Application
  • 9.2.4 By Specimen Type
  • 9.2.5 By End User
  • 9.2.6 United States
  • 9.2.7 Canada
  • 9.2.8 Mexico
• 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.3.1 By Product & Service
  • 9.3.2 By Technology
  • 9.3.3 By Application
  • 9.3.4 By Specimen Type
  • 9.3.5 By End User
  • 9.3.6 United Kingdom
  • 9.3.7 France
  • 9.3.8 Germany
  • 9.3.9 Italy
  • 9.3.10 Russia
  • 9.3.11 Rest Of Europe
• 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.4.1 By Product & Service
  • 9.4.2 By Technology
  • 9.4.3 By Application
  • 9.4.4 By Specimen Type
  • 9.4.5 By End User
  • 9.4.6 India
  • 9.4.7 Japan
  • 9.4.8 South Korea
  • 9.4.9 Australia
  • 9.4.10 South East Asia
  • 9.4.11 Rest Of Asia Pacific
• 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.5.1 By Product & Service
  • 9.5.2 By Technology
  • 9.5.3 By Application
  • 9.5.4 By Specimen Type
  • 9.5.5 By End User
  • 9.5.6 Brazil
  • 9.5.7 Argentina
  • 9.5.8 Peru
  • 9.5.9 Chile
  • 9.5.10 Rest of Latin America
• 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.6.1 By Product & Service
  • 9.6.2 By Technology
  • 9.6.3 By Application
  • 9.6.4 By Specimen Type
  • 9.6.5 By End User
  • 9.6.6 Saudi Arabia
  • 9.6.7 UAE
  • 9.6.8 Israel
  • 9.6.9 South Africa
  • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

• 10.1. Recent Developments
• 10.2. Company Categorization
• 10.3. Supply Chain & Channel Partners (based on availability)
• 10.4. Market Share & Positioning Analysis (based on availability)
• 10.5. Vendor Landscape (based on availability)
• 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL IMMUNOASSAY INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Company Profiles
  • 11.2.1 Abbott Laboratories
  • 11.2.2 F. Hoffmann-La Roche AG
  • 11.2.3 Siemens Healthineers AG
  • 11.2.4 Danaher Corporation
  • 11.2.5 Thermo Fisher Scientific Inc
  • 11.2.6 Becton Dickinson And Company
  • 11.2.7 Bio-Rad Laboratories Inc
  • 11.2.8 Hologic Inc
  • 11.2.9 Luminex Corporation
  • 11.2.10 QIAGEN N.V
  • 11.2.11 Sysmex Corporation
  • 11.2.12 Agilent Technologies Inc
  • 11.2.13 BioM erieux SA
  • 11.2.14 DiaSorin S.p.A
  • 11.2.15 Ortho Clinical Diagnostics
  • 11.2.16 Tosoh Bioscience Inc
  • 11.2.17 Shenzhen Mindray Bio-Medical
  • 11.2.18 Merck KGaA
  • 11.2.19 QuidelOrtho Corporation